 Kelly Sullivan
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 22 | 2026 | 534 | 3.630 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 529 | 2.040 |
Why?
| | Proteome | 6 | 2026 | 518 | 1.110 |
Why?
| | Interferons | 6 | 2026 | 188 | 0.940 |
Why?
| | Apoptosis | 14 | 2023 | 2430 | 0.880 |
Why?
| | Piperazines | 6 | 2023 | 381 | 0.870 |
Why?
| | Transcriptome | 8 | 2026 | 1045 | 0.800 |
Why?
| | Liposarcoma | 1 | 2023 | 31 | 0.780 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 66 | 0.740 |
Why?
| | Genes, p53 | 2 | 2012 | 67 | 0.720 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 29 | 0.660 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.660 |
Why?
| | Transcriptional Activation | 3 | 2022 | 383 | 0.660 |
Why?
| | Azetidines | 1 | 2020 | 45 | 0.650 |
Why?
| | Databases, Genetic | 1 | 2021 | 248 | 0.630 |
Why?
| | Metabolome | 3 | 2026 | 384 | 0.620 |
Why?
| | Nuclear Proteins | 6 | 2017 | 748 | 0.620 |
Why?
| | Liver | 2 | 2026 | 1887 | 0.600 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2009 | 28 | 0.590 |
Why?
| | Neoplasms | 8 | 2023 | 2875 | 0.580 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 321 | 0.550 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 82 | 0.530 |
Why?
| | Hypersensitivity | 1 | 2020 | 252 | 0.530 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 69 | 0.520 |
Why?
| | Imidazoles | 4 | 2023 | 254 | 0.500 |
Why?
| | Sulfonamides | 1 | 2020 | 580 | 0.490 |
Why?
| | Histones | 4 | 2009 | 669 | 0.480 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1455 | 0.470 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2194 | 0.460 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 969 | 0.460 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 210 | 0.450 |
Why?
| | Isoquinolines | 1 | 2015 | 44 | 0.450 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 5 | 0.450 |
Why?
| | Receptors, Interferon | 3 | 2026 | 60 | 0.430 |
Why?
| | Immunity, Innate | 2 | 2020 | 846 | 0.420 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1499 | 0.370 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 2 | 2009 | 10 | 0.370 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 628 | 0.370 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 0.360 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 621 | 0.350 |
Why?
| | RNA, Messenger | 3 | 2020 | 2832 | 0.350 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 75 | 0.350 |
Why?
| | Patient Selection | 1 | 2015 | 719 | 0.340 |
Why?
| | Interferon-alpha | 3 | 2020 | 197 | 0.330 |
Why?
| | Fibroblasts | 1 | 2016 | 1034 | 0.330 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1782 | 0.300 |
Why?
| | Mice | 15 | 2026 | 18339 | 0.300 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 177 | 0.300 |
Why?
| | Medulloblastoma | 2 | 2022 | 215 | 0.290 |
Why?
| | Humans | 45 | 2026 | 144759 | 0.290 |
Why?
| | Animals | 21 | 2026 | 38058 | 0.290 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2009 | 121 | 0.280 |
Why?
| | Membrane Proteins | 1 | 2015 | 1166 | 0.280 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.270 |
Why?
| | Hypoxia | 2 | 2026 | 1199 | 0.260 |
Why?
| | Drosophila Proteins | 1 | 2009 | 212 | 0.260 |
Why?
| | Signal Transduction | 7 | 2024 | 5226 | 0.260 |
Why?
| | HCT116 Cells | 3 | 2017 | 78 | 0.250 |
Why?
| | Pyrimidines | 2 | 2024 | 532 | 0.250 |
Why?
| | Biomarkers | 3 | 2022 | 4271 | 0.240 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.240 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.240 |
Why?
| | Platelet Activation | 1 | 2026 | 104 | 0.230 |
Why?
| | Human Development | 1 | 2025 | 21 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 28 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2026 | 784 | 0.210 |
Why?
| | Bile Acids and Salts | 1 | 2026 | 164 | 0.210 |
Why?
| | Datasets as Topic | 2 | 2022 | 122 | 0.210 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.210 |
Why?
| | Cell Proliferation | 7 | 2023 | 2496 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 623 | 0.210 |
Why?
| | Autophagy | 2 | 2018 | 286 | 0.200 |
Why?
| | Disease Models, Animal | 5 | 2026 | 4557 | 0.200 |
Why?
| | Heme | 1 | 2024 | 89 | 0.200 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 22 | 0.200 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 40 | 0.200 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.190 |
Why?
| | Piperidines | 1 | 2024 | 217 | 0.190 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.190 |
Why?
| | Female | 18 | 2026 | 78271 | 0.190 |
Why?
| | Centrosome | 2 | 2023 | 71 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 436 | 0.180 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 159 | 0.180 |
Why?
| | Purines | 2 | 2020 | 187 | 0.180 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3540 | 0.180 |
Why?
| | Blood | 1 | 2022 | 109 | 0.170 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 197 | 0.170 |
Why?
| | Male | 13 | 2026 | 72315 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 48 | 0.170 |
Why?
| | Cilia | 2 | 2023 | 173 | 0.170 |
Why?
| | Autoimmunity | 3 | 2024 | 926 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 383 | 0.170 |
Why?
| | Seroconversion | 1 | 2021 | 49 | 0.160 |
Why?
| | Cytokines | 4 | 2024 | 2061 | 0.160 |
Why?
| | RNA Interference | 2 | 2015 | 476 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 117 | 0.160 |
Why?
| | Cell Line | 5 | 2021 | 2882 | 0.160 |
Why?
| | Pyrazoles | 2 | 2022 | 509 | 0.160 |
Why?
| | RNA Helicases | 1 | 2020 | 31 | 0.160 |
Why?
| | Sex Characteristics | 1 | 2025 | 790 | 0.150 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 194 | 0.150 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1496 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2022 | 3604 | 0.150 |
Why?
| | Heart Defects, Congenital | 2 | 2026 | 914 | 0.140 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2930 | 0.140 |
Why?
| | Protein Domains | 2 | 2017 | 313 | 0.140 |
Why?
| | Kynurenine | 1 | 2019 | 114 | 0.140 |
Why?
| | DNA Repair | 1 | 2021 | 256 | 0.140 |
Why?
| | Metabolomics | 2 | 2021 | 727 | 0.140 |
Why?
| | Young Adult | 5 | 2025 | 14105 | 0.140 |
Why?
| | Complement System Proteins | 2 | 2021 | 316 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.140 |
Why?
| | Proteomics | 2 | 2023 | 1195 | 0.130 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 56 | 0.130 |
Why?
| | RNA Precursors | 2 | 2009 | 156 | 0.130 |
Why?
| | Cell Cycle | 2 | 2012 | 596 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 415 | 0.130 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 50 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 186 | 0.130 |
Why?
| | Adult | 9 | 2026 | 40449 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.130 |
Why?
| | Caspases | 2 | 2015 | 232 | 0.130 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 458 | 0.130 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 99 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | Antigens | 1 | 2018 | 347 | 0.120 |
Why?
| | Child, Preschool | 5 | 2025 | 11787 | 0.120 |
Why?
| | Down-Regulation | 2 | 2017 | 627 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 192 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 173 | 0.120 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 462 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 162 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 259 | 0.110 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 5992 | 0.110 |
Why?
| | Genomics | 1 | 2021 | 834 | 0.110 |
Why?
| | Child | 7 | 2026 | 22633 | 0.110 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.110 |
Why?
| | Pyrones | 1 | 2015 | 10 | 0.110 |
Why?
| | Caspase 8 | 1 | 2015 | 47 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 54 | 0.110 |
Why?
| | Cells, Cultured | 3 | 2018 | 4154 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1980 | 0.110 |
Why?
| | Transcription Factors | 2 | 2022 | 1741 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 107 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 737 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2017 | 437 | 0.100 |
Why?
| | Morpholines | 1 | 2015 | 128 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 396 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 138 | 0.100 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.100 |
Why?
| | Fluorouracil | 1 | 2015 | 235 | 0.100 |
Why?
| | Base Sequence | 3 | 2020 | 2190 | 0.100 |
Why?
| | Monocytes | 1 | 2016 | 538 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 240 | 0.100 |
Why?
| | Naphthalenes | 1 | 2013 | 56 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 766 | 0.100 |
Why?
| | Ligands | 1 | 2015 | 673 | 0.090 |
Why?
| | Genes, Synthetic | 1 | 2012 | 14 | 0.090 |
Why?
| | Genes, Lethal | 1 | 2012 | 30 | 0.090 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 862 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 635 | 0.090 |
Why?
| | Infant | 3 | 2025 | 10034 | 0.090 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 215 | 0.090 |
Why?
| | Adolescent | 5 | 2025 | 22428 | 0.090 |
Why?
| | Autoantigens | 2 | 2023 | 429 | 0.090 |
Why?
| | Chronic Disease | 1 | 2017 | 1813 | 0.090 |
Why?
| | Telomerase | 1 | 2013 | 248 | 0.080 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 337 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2155 | 0.080 |
Why?
| | Phenotype | 3 | 2026 | 3162 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2608 | 0.080 |
Why?
| | Hematopoiesis | 2 | 2021 | 194 | 0.080 |
Why?
| | Lipids | 1 | 2015 | 710 | 0.080 |
Why?
| | Cleavage Stimulation Factor | 1 | 2009 | 4 | 0.080 |
Why?
| | Endonucleases | 1 | 2008 | 34 | 0.070 |
Why?
| | Exoribonucleases | 1 | 2008 | 45 | 0.070 |
Why?
| | Middle Aged | 4 | 2025 | 35875 | 0.070 |
Why?
| | Mitochondria | 1 | 2015 | 984 | 0.070 |
Why?
| | Mutation | 3 | 2015 | 4089 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1982 | 0.070 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2008 | 92 | 0.070 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 336 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 172 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 236 | 0.060 |
Why?
| | Candida albicans | 1 | 2026 | 61 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2009 | 618 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2637 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2452 | 0.060 |
Why?
| | Vascular Remodeling | 1 | 2026 | 205 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2026 | 348 | 0.050 |
Why?
| | HeLa Cells | 3 | 2013 | 650 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 66 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 217 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 100 | 0.050 |
Why?
| | Proline | 1 | 2023 | 83 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 33 | 0.050 |
Why?
| | Blood Platelets | 1 | 2026 | 400 | 0.050 |
Why?
| | Centrioles | 1 | 2023 | 47 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 86 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 44 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.040 |
Why?
| | Protein Binding | 2 | 2020 | 2273 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 28 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1329 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2024 | 453 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 172 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 319 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 266 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 22 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.040 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 25 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 167 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 55 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 152 | 0.040 |
Why?
| | Gene Silencing | 1 | 2020 | 205 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 33 | 0.030 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 76 | 0.030 |
Why?
| | Phosphorylation | 1 | 2022 | 1732 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 26 | 0.030 |
Why?
| | Hexokinase | 1 | 2017 | 18 | 0.030 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 15 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 411 | 0.030 |
Why?
| | Cell Lineage | 1 | 2019 | 376 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2017 | 51 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 545 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2017 | 135 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1501 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 17 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 640 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 442 | 0.030 |
Why?
| | Proteins | 1 | 2023 | 1021 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 381 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 389 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2017 | 247 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 40 | 0.030 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 123 | 0.030 |
Why?
| | Gene Editing | 1 | 2017 | 93 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 919 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 72 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1658 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1126 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1173 | 0.030 |
Why?
| | Glycolysis | 1 | 2017 | 339 | 0.030 |
Why?
| | Cohort Studies | 1 | 2026 | 5960 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 62 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 41 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1490 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 965 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 26 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 946 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 917 | 0.020 |
Why?
| | Models, Biological | 1 | 2021 | 1821 | 0.020 |
Why?
| | Protein Transport | 1 | 2014 | 441 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 961 | 0.020 |
Why?
| | Lung | 1 | 2026 | 4109 | 0.020 |
Why?
| | Obesity | 1 | 2026 | 3077 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 380 | 0.020 |
Why?
| | Chromatin | 1 | 2016 | 561 | 0.020 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 119 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 928 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2050 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2433 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1313 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1098 | 0.020 |
Why?
| | Ribonucleoprotein, U7 Small Nuclear | 1 | 2008 | 2 | 0.020 |
Why?
| | Phosphorus Radioisotopes | 1 | 2008 | 26 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2008 | 16 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2008 | 96 | 0.020 |
Why?
| | Nucleotides | 1 | 2008 | 128 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 388 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 180 | 0.020 |
Why?
| | RNA Stability | 1 | 2008 | 119 | 0.020 |
Why?
| | RNA | 1 | 2014 | 940 | 0.020 |
Why?
| | Drosophila | 1 | 2008 | 166 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2006 | 337 | 0.010 |
Why?
| | Genotype | 1 | 2006 | 1833 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1463 | 0.010 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|